The gut pathogen Clostridium bolteae has been associated with the onset of autism spectrum disorder (ASD). To create vaccines against C. bolteae,itisimportant to identify exact protective epitopes of the immunologically active capsular polysaccharide (CPS). Here,aseries of C. bolteae CPS glycans,u pt oa no ctadecasaccharide,w as prepared. Keyt o achieving the total syntheses is a[2+ +2] coupling strategy based on a b-d-Rhap-(1!3)-ad -Manp repeating unit that in turn was accessed by astereoselective b-d-rhamnosylation. The 4,6-O-benzylidene-induced conformational locking is ap owerful strategy for forming a b-d-mannose-type glycoside.Anindirect strategy based on C2 epimerization of b-d-quinovoside was efficiently achieved by Swern oxidation and borohydride reduction. Sequential glycosylation, and regioselective and global deprotection produced the disaccharide and tetrasaccharide,u pt ot he octadecasaccharide.G lycan microarray analysis of sera from rabbits immunized with inactivated C. bolteae bacteria revealed ahumoral immune response to the diand tetrasaccharide,b ut none of the longer sequences.T he tetrasaccharide may be ak ey motif for designing glycoconjugate vaccines against C. bolteae.